Table of Content

1 Study Coverage
1.1 RNAi for Therapeutic Product Introduction
1.2 Market by Type
1.2.1 Global RNAi for Therapeutic Market Size Growth Rate by Type, 2019 VS 2024 VS 2030
1.3 Market by Application
1.3.1 Global RNAi for Therapeutic Market Size Growth Rate by Application, 2019 VS 2024 VS 2030
1.4 Study Objectives
1.5 Years Considered
1.6 Currency Exchange Rate
1.7 Inflation Analysis
1.8 The Impact of the Russian-Ukrainian War on the Market
1.9 Coronavirus Disease (COVID-19) Impact on Global
2 Competition by Players
2.1 Global RNAi for Therapeutic Sales by Players
2.1.1 Global RNAi for Therapeutic Sales by Players (2019-2024)
2.1.2 Global RNAi for Therapeutic Sales Market Share by Players (2019-2024)
2.1.3 Global Top 5 and Top 10 Largest Players of RNAi for Therapeutic in 2024
2.2 Global RNAi for Therapeutic Revenue by Players
2.2.1 Global RNAi for Therapeutic Revenue by Players (2019-2024)
2.2.2 Global RNAi for Therapeutic Revenue Market Share by Players (2019-2024)
2.2.3 Global Top 5 and Top 10 Companies by RNAi for Therapeutic Revenue in 2024
2.3 Global RNAi for Therapeutic Sales Price by Players
2.4 Analysis of Competitive Landscape
2.4.1 Players Market Concentration Ratio (CR5)
2.4.2 Global RNAi for Therapeutic Players Geographical Distribution
2.5 Mergers & Acquisitions, Expansion Plans
3 Company Overview
3.1 Enzon Pharmaceuticals (Santaris Pharma)
3.1.1 Enzon Pharmaceuticals (Santaris Pharma) Information
3.1.2 Enzon Pharmaceuticals (Santaris Pharma) Overview
3.1.3 Enzon Pharmaceuticals (Santaris Pharma) RNAi for Therapeutic Sales, Price, Revenue and Gross Margin (2019-2024)
3.1.4 Enzon Pharmaceuticals (Santaris Pharma) Related Developments
3.2 University of Texas
3.2.1 University of Texas Information
3.2.2 University of Texas Overview
3.2.3 University of Texas RNAi for Therapeutic Sales, Price, Revenue and Gross Margin (2019-2024)
3.2.4 University of Texas Related Developments
3.3 OncoGenex
3.3.1 OncoGenex Information
3.3.2 OncoGenex Overview
3.3.3 OncoGenex RNAi for Therapeutic Sales, Price, Revenue and Gross Margin (2019-2024)
3.3.4 OncoGenex Related Developments
3.4 Isarna Therapeutics
3.4.1 Isarna Therapeutics Information
3.4.2 Isarna Therapeutics Overview
3.4.3 Isarna Therapeutics RNAi for Therapeutic Sales, Price, Revenue and Gross Margin (2019-2024)
3.4.4 Isarna Therapeutics Related Developments
3.5 Astrazeneca (Ionis Pharmaceuticals)
3.5.1 Astrazeneca (Ionis Pharmaceuticals) Information
3.5.2 Astrazeneca (Ionis Pharmaceuticals) Overview
3.5.3 Astrazeneca (Ionis Pharmaceuticals) RNAi for Therapeutic Sales, Price, Revenue and Gross Margin (2019-2024)
3.5.4 Astrazeneca (Ionis Pharmaceuticals) Related Developments
3.6 INSYS Therapeutics Inc
3.6.1 INSYS Therapeutics Inc Information
3.6.2 INSYS Therapeutics Inc Overview
3.6.3 INSYS Therapeutics Inc RNAi for Therapeutic Sales, Price, Revenue and Gross Margin (2019-2024)
3.6.4 INSYS Therapeutics Inc Related Developments
4 Market Size by Type
4.1 Global RNAi for Therapeutic Sales by Type
4.1.1 Global RNAi for Therapeutic Sales by Type (2019-2024)
4.1.2 Global RNAi for Therapeutic Forecasted Sales by Type (2024-2030)
4.2 Global RNAi for Therapeutic Revenue by Type
4.2.1 Global RNAi for Therapeutic Revenue by Type (2019-2024)
4.2.2 Global RNAi for Therapeutic Forecasted Revenue by Type (2024-2030)
4.3 Global RNAi for Therapeutic Price by Type
4.3.1 Global RNAi for Therapeutic Price by Type (2019-2024)
4.3.2 Global RNAi for Therapeutic Price Forecast by Type (2024-2030)
5 Market Size by Application
5.1 Global RNAi for Therapeutic Sales by Application
5.1.1 Global RNAi for Therapeutic Sales by Application (2019-2024)
5.1.2 Global RNAi for Therapeutic Forecasted Sales by Application (2024-2030)
5.2 Global RNAi for Therapeutic Revenue by Application
5.2.1 Global RNAi for Therapeutic Revenue by Application (2019-2024)
5.2.2 Global RNAi for Therapeutic Forecasted Revenue by Application (2024-2030)
5.3 Global RNAi for Therapeutic Price by Application
5.3.1 Global RNAi for Therapeutic Price by Application (2019-2024)
5.3.2 Global RNAi for Therapeutic Price Forecast by Application (2024-2030)
6 Global RNAi for Therapeutic Production
6.1 Global RNAi for Therapeutic Production (2019-2030)
6.2 Global RNAi for Therapeutic Production by Region: 2019 VS 2024 VS 2030
6.3 Global RNAi for Therapeutic Production by Region
6.3.1 Global RNAi for Therapeutic Historic Production by Region (2019-2024)
6.3.2 Global RNAi for Therapeutic Forecasted Production by Region (2024-2030)
6.4 North America
6.5 Europe
6.6 China
6.7 Japan
7 Global RNAi for Therapeutic Market Insights Estimates and Forecasts
7.1 Global RNAi for Therapeutic Sales Estimates and Forecasts 2019-2030
7.2 Global RNAi for Therapeutic Revenue Estimates and Forecasts 2019-2030
7.3 Global RNAi for Therapeutic Sales by Region: 2019 VS 2024 VS 2030
7.4 Global RNAi for Therapeutic Sales by Region
7.4.1 Global RNAi for Therapeutic Sales by Region (2019-2024)
7.4.2 Global RNAi for Therapeutic Sales by Region (2024-2030)
7.5 Global RNAi for Therapeutic Revenue by Region
7.5.1 Global RNAi for Therapeutic Revenue by Region (2019-2024)
7.5.2 Global RNAi for Therapeutic Revenue by Region (2024-2030)
7.6 North America
7.7 Europe
7.8 Asia-Pacific
7.9 Latin America
7.10 Middle East & Africa
8 North America
8.1 North America RNAi for Therapeutic Market Size by Country
8.1.1 North America RNAi for Therapeutic Sales by Country (2019-2030)
8.1.2 North America RNAi for Therapeutic Revenue by Country (2019-2030)
8.1.3 U.S.
8.1.4 Canada
9 Europe
9.1 Europe RNAi for Therapeutic Market Size by Country
9.1.1 Europe RNAi for Therapeutic Sales by Country (2019-2030)
9.1.2 Europe RNAi for Therapeutic Revenue by Country (2019-2030)
9.1.3 Germany
9.1.4 France
9.1.5 U.K.
9.1.6 Italy
9.1.7 Russia
10 Asia Pacific
10.1 Asia Pacific RNAi for Therapeutic Market Size by Region
10.1.1 Asia Pacific RNAi for Therapeutic Sales by Region (2019-2030)
10.1.2 Asia Pacific RNAi for Therapeutic Revenue by Region (2019-2030)
10.1.3 China
10.1.4 Japan
10.1.5 South Korea
10.1.6 India
10.1.7 Southeast Asia
10.1.8 Australia
11 Latin America
11.1 Latin America RNAi for Therapeutic Market Size by Country
11.1.1 Latin America RNAi for Therapeutic Sales by Country (2019-2030)
11.1.2 Latin America RNAi for Therapeutic Revenue by Country (2019-2030)
11.1.3 Mexico
11.1.4 Brazil
12 Middle East and Africa
12.1 Middle East and Africa RNAi for Therapeutic Market Size by Country
12.1.1 Middle East and Africa RNAi for Therapeutic Sales by Country (2019-2030)
12.1.2 Middle East and Africa RNAi for Therapeutic Revenue by Country (2019-2030)
12.1.3 Turkey
12.1.4 Saudi Arabia
12.1.5 U.A.E
13 Value Chain and Channels Analysis
13.1 RNAi for Therapeutic Value Chain Analysis
13.2 RNAi for Therapeutic Key Raw Materials
13.2.1 Key Raw Materials
13.2.2 Raw Materials Key Suppliers
13.3 RNAi for Therapeutic Production Mode & Process
13.4 RNAi for Therapeutic Sales and Marketing
13.4.1 RNAi for Therapeutic Sales Channels
13.4.2 RNAi for Therapeutic Distributors
13.5 RNAi for Therapeutic Customers
14 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
14.1 RNAi for Therapeutic Industry Trends
14.2 RNAi for Therapeutic Market Drivers
14.3 RNAi for Therapeutic Market Challenges
14.4 RNAi for Therapeutic Market Restraints
14.5 RNAi for Therapeutic Market Technology Analysis
15 Research Findings and Conclusion
16 Methodology and Data Source
16.1 Methodology
16.1.1 Research Process
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Legal Disclaimer